Design Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Design Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2024.
  • Design Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -17.4 %, a 23.3% increase year-over-year.
  • Design Therapeutics, Inc. annual Return On Assets for 2023 was -21.8 %, a 24.3% decline from 2022.
  • Design Therapeutics, Inc. annual Return On Assets for 2022 was -17.6 %, a 98.6% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -17.4 +5.28 +23.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -17.8 +4.54 +20.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -19.9 +0.09 +0.45% Jan 1, 2024 Mar 31, 2024
Q4 2023 -21.8 -4.26 -24.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -22.7 -7.37 -48.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22.3 -9.13 -69.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -20 -8.98 -81.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -17.6 -8.72 -98.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -15.3 -6.26 -69.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -13.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 -11 Jan 1, 2022 Mar 31, 2022
Q4 2021 -8.84 Oct 1, 2021 Dec 31, 2021
Q3 2021 -9.04 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.